Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
WCLC 2021
2021 World Conference on Lung Cancer
Presentation Date(s):- September 8 - 14, 2021
- Total Presentations: 1107
-
+
P47 - Novel Therapeutics and Targeted Therapies - Clinical Trial in Progress
- Type: Posters
- Track: Novel Therapeutics and Targeted Therapies
- Presentations: 18
- Coordinates: 9/08/2021, 00:00 - 00:00, ePoster Hall
-
+
P47.09 - Tepotinib + Osimertinib for EGFR-Mutant NSCLC with Resistance to First-Line Osimertinib Due to MET amplification: INSIGHT 2
00:00 - 00:00 | Presenter: Christophe Dooms
- Abstract
Loading...
-
+
P50 - Novel Therapeutics and Targeted Therapies - EGFR Minor
- Type: Posters
- Track: Novel Therapeutics and Targeted Therapies
- Presentations: 8
- Coordinates: 9/08/2021, 00:00 - 00:00, ePoster Hall
-
+
P50.01 - RELAY, Erlotinib Plus Ramucirumab in Untreated, EGFR-Mutated, Metastatic NSCLC: Outcomes by EGFR Exon 19-del Variants
00:00 - 00:00 | Presenter: Kazumi Nishino
- Abstract
Loading...
-
+
OA09 - Expanding Immunotherapy Options for Non-Small Cell Lung Cancers
- Type: Oral
- Track: Immunotherapy (Phase II/III Trials)
- Presentations: 5
- Moderators:Rina Hui
- Coordinates: 9/09/2021, 09:30 - 10:30, Program Auditorium
-
+
OA09.02 - Atezo-Brain: Single Arm Phase II Study of Atezolizumab Plus Chemotherapy in Stage IV NSCLC With Untreated Brain Metastases
09:40 - 09:50 | Presenter: Ernest Nadal
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
MA14 - Pathologic Patterns, Genomic Alterations and Targeted Therapies in NSCLC
- Type: Mini Oral
- Track: Predictive Tumor Based Assays/ Biomarkers/ Pathology
- Presentations: 8
- Coordinates: 9/13/2021, 18:45 - 19:45, Program Auditorium
-
+
MA14.02 - RET Fusion Testing in Advanced Non-Small Cell Lung Carcinoma Patients: the RETING Study
18:50 - 18:55 | Author(s): Esther Conde
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
OA20 - Exploring Treatment Modalities and Tools in Locally Advanced NSCLC
- Type: Oral
- Track: Locally Advanced Non-Small Cell Lung Cancer
- Presentations: 7
- Moderators:Leena Gandhi
- Coordinates: 9/13/2021, 18:45 - 19:45, Program Auditorium
-
+
OA20.01 - Long Term Survival in Operable Stage Iiia Nsclc Patients Treated With Neoadjuvant Nivolumab Plus Chemotherapy - Nadim Study
18:45 - 18:53 | Presenter: Mariano Provencio
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
OA20.02 - Pre-Treatment Levels of ctDNA for Long-Term Survival Prediction in Stage IIIA NSCLC Treated With Neoadjuvant Chemo-Immunotherapy
18:53 - 19:01 | Presenter: Atocha Romero
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.